Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Huaping Fu"'
Autor:
Lin Fu, Huaping Fu, Qingyun Wu, Yifan Pang, Keman Xu, Lei Zhou, Jianlin Qiao, Xiaoyan Ke, Kailin Xu, Jinlong Shi
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background ETS2 is a downstream effector of the RAS/RAF/ERK pathway, which plays a critical role in the development of malignant tumor. However, the clinical impact of ETS2 expression in AML remains unknown. Methods In this study, we evaluat
Externí odkaz:
https://doaj.org/article/f234f8656be44aed8dd9f9a139bbb371
Publikováno v:
Clinical nuclear medicine. 47(6)
To evaluate the diagnostic potential of decision-tree model of diffusion kurtosis imaging (DKI) and 11C-methionine (11C-MET) PET, for the differentiation of radiotherapy (RT) injury from glioblastoma recurrence.Eighty-six glioblastoma cases with susp
Autor:
Yifan Pang, Zhenyu Li, Jianlin Qiao, Jinlong Shi, Keman Xu, Xiaoyan Ke, Qing-Yun Wu, Huaping Fu, Lei Zhou, Kailin Xu, Lin Fu
Publikováno v:
Cancer Science
CPNE3, a member of a Ca2+‐dependent phospholipid‐binding protein family, was identified as a ligand of ERBB2 and has a more general role in carcinogenesis. Here, we identified the prognostic significance of CPNE3 expression in acute myeloid leuke
Autor:
Xiaoyan Ke, Hongmei Jing, Huaping Fu, Jing Wang, Jinlong Shi, Kai Hu, Lei Tian, Keman Xu, Ji-Jun Wang, Lin Fu
Publikováno v:
Oncotarget
Depending on its expression level, RUNX1 can act as a tumor promoter or suppressor in hematological malignancies. The clinical impact of RUNX1 expression in cytogenetically normal acute myeloid leukemia (CN-AML) remained unknown, however. We evaluate
Autor:
Sun Wu, Li Chen, Keman Xu, Chao Wang, Jinlong Shi, Huaping Fu, Hongmian Zhao, Lin Fu, Yu Han, Yifan Pang, Zhiheng Cheng, Tong Qin, Xiaoyan Ke, Yijie Zhang, Kailin Xu
Publikováno v:
Blood Cancer Journal, Vol 7, Iss 12, Pp 1-5 (2017)
Blood Cancer Journal
Blood Cancer Journal
Autor:
Jianlin Qiao, Keman Xu, Xiaoyan Ke, Lin Fu, Kailin Xu, Huaping Fu, Qing-Yun Wu, Lei Zhou, Yifan Pang, Jinlong Shi
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Background ETS2 is a downstream effector of the RAS/RAF/ERK pathway, which plays a critical role in the development of malignant tumor. However, the clinical impact of ETS2 expression in AML remains unknown. Methods In this study, we evaluated the pr
Autor:
Fu, Lin, Huaping Fu, Qingyun Wu, Yifan Pang, Keman Xu, Zhou, Lei, Jianlin Qiao, Xiaoyan Ke, Kailin Xu, Jinlong Shi
Additional file 1. The hierarchical differentiation tree of relationship between ETS2 expression level and hematopoietic cell differentiation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06dafa1abf0489c94ab695da5acad9e1
Publikováno v:
EBioMedicine
Carnitine palmitoyl transferase 1A (CPT1A) protein catalyzes the rate-limiting step of Fatty-acid oxidation (FAO) pathway, which can promote cell proliferation and suppress apoptosis. Targeting CPT1A has shown remarkable anti-leukemia activity. But,
Autor:
Jing Wang, Huaping Fu, Keman Xu, Lin Fu, Jinlong Shi, Yuanyuan Liu, Kai Hu, Wenrong Huang, Ji-Jun Wang, Xiaoyan Ke, Lei Zhou, Hongmei Jing, Yifan Pang, Lei Tian
Publikováno v:
Scientific Reports
Microtubule-associated protein 7 (MAP7) plays an important role in cancer cells. In this study, we identified the prognostic significance of MAP7 expression in cytogenetically normal acute myeloid leukemia (CN-AML) patients (aged MAP7 expression (MAP
Autor:
Lin, Fu, Shi, Jinlong, Liu, Anqi, Zhou, Lei, Jiang, Mengmeng, Huaping, Fu, Keman, Xu, Dandan, Li, Deng, Ailing, Zhang, Qingyi, Pang, Yifan, Guo, Yujie, Kai, Hu, Zhou, Jiansuo, Wang, Yapeng, Huang, Wenrong, Jing, Yu, Dou, Liping, Wang, Lili, Kailin, Xu, Xiaoyan, Ke, Nervi, Clara, Yonghui, Li, Li, Yu
Publikováno v:
International journal of cancer. 140(3)
MicroRNA-9-1(miR-9-1) plays an important role in the mechanism that regulates the lineage fate of differentiating hematopoietic cells. Recent studies have shown that miR-9-1 is downregulated in t (8; 21) AML. However, the pathogenic mechanisms underl